YU1800A - Use of a bisphosphonate for production drug for a bone resorption inhibiting - Google Patents

Use of a bisphosphonate for production drug for a bone resorption inhibiting

Info

Publication number
YU1800A
YU1800A YU1800A YU1800A YU1800A YU 1800 A YU1800 A YU 1800A YU 1800 A YU1800 A YU 1800A YU 1800 A YU1800 A YU 1800A YU 1800 A YU1800 A YU 1800A
Authority
YU
Yugoslavia
Prior art keywords
bone resorption
bisphosphonate
disclosed
resorption inhibiting
production drug
Prior art date
Application number
YU1800A
Other languages
Serbo-Croatian (sh)
Inventor
Anastasia G. Daifotis
Arthur C. Ii Santora
A. John Yates
Original Assignee
Merk & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43743642&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU1800(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9717590.5A external-priority patent/GB9717590D0/en
Priority claimed from GBGB9717850.3A external-priority patent/GB9717850D0/en
Application filed by Merk & Co. Inc. filed Critical Merk & Co. Inc.
Publication of YU1800A publication Critical patent/YU1800A/en
Publication of RS49979B publication Critical patent/RS49979B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Disclosed are methods for inhibiting bone resorption in mammals while minimizing the occurrence of or potential for adverse gastrointestinal effects. Also disclosed are pharmaceutical compositions and kits for carrying out the therapeutic methods disclosed herein. The compounds are bisphosphonates selected from the group consisting of alendronate, cimadronate, clodronate, tiludronate, etridronate, ibandronate, risedronate, piridronate, pamidronate, zolendronate, optionally in combination with a histamine H2 antagonist.
YUP-18/00A 1997-07-22 1998-07-17 Use of a bisphosphnate in the manufacture of a medicament for inhibiting bone resorption RS49979B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US5335197P 1997-07-22 1997-07-22
US5353597P 1997-07-23 1997-07-23
GBGB9717590.5A GB9717590D0 (en) 1997-08-20 1997-08-20 Oral method for treating or preventing abnormal bone resorption
GBGB9717850.3A GB9717850D0 (en) 1997-08-22 1997-08-22 Oral method for treating or preventing abnormal bone resorption

Publications (2)

Publication Number Publication Date
YU1800A true YU1800A (en) 2002-08-12
RS49979B RS49979B (en) 2008-09-29

Family

ID=43743642

Country Status (5)

Country Link
ME (1) ME00862B (en)
RS (1) RS49979B (en)
SI (1) SI1175904T1 (en)
TR (1) TR200805763T2 (en)
UA (1) UA67748C2 (en)

Also Published As

Publication number Publication date
SI1175904T1 (en) 2007-06-30
TR200805763T2 (en) 2011-05-23
RS49979B (en) 2008-09-29
UA67748C2 (en) 2004-07-15
ME00862B (en) 2008-09-29

Similar Documents

Publication Publication Date Title
LU91364I2 (en) Sodium alendronate / colecalciferol
NZ545804A (en) Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate
NZ272608A (en) Inhibiting bone loss by administering a bisphosphonate and a second compound selected from various compounds, including 2-phenyl-3-aroylbenzothienes; bisphosphonate combination salts
YU1800A (en) Use of a bisphosphonate for production drug for a bone resorption inhibiting
PE120399A1 (en) COMPOSITIONS INHIBITING OSEA RESORPTION